# Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair

> **NCT00139152** · PHASE4 · COMPLETED · sponsor: **Creighton University** · enrollment: 65 (actual)

## Conditions studied

- Lung Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** Xolair

## Key facts

- **NCT ID:** NCT00139152
- **Lead sponsor:** Creighton University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2014-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00139152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00139152, "Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00139152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*